Market Cap 464.02M
Revenue (ttm) 9.00M
Net Income (ttm) -80.61M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -895.67%
Debt to Equity Ratio 0.00
Volume 504,200
Avg Vol 957,794
Day's Range N/A - N/A
Shares Out 45.90M
Stochastic %K 40%
Beta 0.93
Analysts Strong Sell
Price Target $35.62

Company Profile

BioAge Labs, Inc., a clinical-stage biopharmaceutical company, develops therapeutic product candidates for metabolic diseases. The company's technology platform and differentiated human datasets that allows users to identify targets based on insights into molecular changes that drive aging. Its lead product candidate includes BGE-102, an orally available brain-penetrant small-molecule NLRP3 inhibitor which is in Phase 1 clinical trail for the treatment of atherosclerotic cardiovascular disease,...

Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Phone: 510 806 1445
Address:
5885 Hollis Street, Suite 370, EmeryVille, United States
B2iDigital
B2iDigital Aug. 25 at 8:42 PM
BioAge Labs, Inc. ($BIOA ) meets investors at the 5th Annual ROTH Healthcare Opportunities Conference, hosted by ROTH Capital Partners at The Metropolitan Club in New York City on Tuesday, September 29, 2026, where B2i Digital is the Marketing Partner. The 5th Annual ROTH Healthcare Opportunities Conference is a B2i Digital Featured Conference. See event details and profiles of participating companies at: https://b2idigital.com/5th-annual-roth-healthcare-opportunities-conference BioAge Labs is a clinical-stage biopharmaceutical company working on metabolic disease: • The company develops therapeutic products for metabolic diseases such as obesity by targeting human biology • Azelaprag is a potential oral therapeutic for obesity • Several earlier-stage metabolic programs sit behind it in the pipeline • The company was founded on April 1, 2015 and is headquartered in Emeryville, California Credit to the team at ROTH: Byron Roth, Aaron Gurewitz, Isabel Mattson-Pain, Nazan Akdeniz, Otilia "Charo" Montano, Amanda McAdams, James Antonopoulos, Benjamin Bowen, Kris Salinger, Jason Wittes and Boobalan Pachaiyappan, Ph.D. ROTH built the day around time with management, in a 25-minute 1-on-1 and small group format running from 8:00 AM to 4:30 PM that gives institutional investors extended interaction with the executives running these companies. This is an invitation-only event and registration is subject to approval by ROTH. To request registration: https://www.meetmax.com/sched/event_139361/conference_home.html Participating company website: http://www.bioagelabs.com/ B2i Digital, The Capital Markets Matchmaker℠, carries each participating company's story From Marketing to Meetings℠, across its media network with a combined monthly audience of more than 330 million and its own community of 1.7 million+ investors and market participants. ROTH is a relationship-driven investment bank headquartered in Newport Beach, California, focused on serving growth companies and their investors. Learn more at https://www.roth.com. Discover more Featured Companies, Featured Experts, and upcoming Featured Conferences at b2idigital.com. B2i Digital is not a broker-dealer or investment adviser. This post is informational and not an offer or solicitation regarding any security. See the complete Disclosure at https://b2idigital.com/disclaimer.
1 · Reply
teddy2
teddy2 Aug. 21 at 4:32 AM
$BIOA lol this is crazy, it fell because of a different companie’s outcome. Check out the current target prices.
1 · Reply
Rusty_Shackelford2024
Rusty_Shackelford2024 Aug. 19 at 9:54 PM
$BIOA weird volume at the end of the day I think there’s gonna be some kind of announcement tomorrow. Let’s see that pop back to 15. Remember, we’re paying for the sins of Novo. The Street maintains the price target 🤌🏻🤌🏻🤌🏻🤌🏻
0 · Reply
BiodegradableBurger
BiodegradableBurger Aug. 19 at 3:49 PM
$BIOA p O s
0 · Reply
BiodegradableBurger
BiodegradableBurger Aug. 13 at 2:50 PM
$BIOA Anything alive?
0 · Reply
Rusty_Shackelford2024
Rusty_Shackelford2024 Aug. 12 at 12:36 AM
$BIOA this is a range trade between 10.60 and 11.50 right now
0 · Reply
forprofit12
forprofit12 Aug. 11 at 4:27 PM
$BIOA added
0 · Reply
TooMuchFinesse
TooMuchFinesse Aug. 9 at 4:48 AM
$BIOA Kind of late to scoop the over reaction news but I think I’ll start loading here
2 · Reply
TooMuchFinesse
TooMuchFinesse Aug. 8 at 6:22 PM
$CMPX $PMVP $BIOA $VIR What do these all have in common? Undervalued Institutions loaded Tang Capital & Orbimed ✅💰🔥 🕳️ 🐇
0 · Reply
Eko86
Eko86 Aug. 7 at 5:58 PM
$BIOA $8.88 entry because I like even numbers.... $20 sale pending lllol
1 · Reply
Latest News on BIOA
BioAge Labs price target lowered to $21 from $52 at Citi

2026-08-06T10:57:06.000Z - 20 days ago

BioAge Labs price target lowered to $21 from $52 at Citi


BioAge Labs reports Q2 EPS (58c), consensus (62c)

2026-08-05T23:00:25.000Z - 21 days ago

BioAge Labs reports Q2 EPS (58c), consensus (62c)


BioAge Labs Quarterly report: Q2 2026

Aug 5, 2026, 7:00 AM EDT - 21 days ago

BioAge Labs Quarterly report: Q2 2026


BioAge Labs Earnings release: Q2 2026

Aug 5, 2026, 7:00 AM EDT - 21 days ago

BioAge Labs Earnings release: Q2 2026


BioAge Labs initiated with a Buy at Roth Capital

2026-05-27T08:20:08.000Z - 3 months ago

BioAge Labs initiated with a Buy at Roth Capital


BioAge Labs to Present at Upcoming Investor Conferences

May 22, 2026, 9:00 AM EDT - 3 months ago

BioAge Labs to Present at Upcoming Investor Conferences


BioAge Labs initiated with a Buy at BTIG

2026-05-13T09:55:09.000Z - 3 months ago

BioAge Labs initiated with a Buy at BTIG


BioAge Labs Transcript: R&D Day 2026

May 8, 2026, 12:30 PM EDT - 3 months ago

BioAge Labs Transcript: R&D Day 2026


BioAge Labs Slides: FY 2026

May 8, 2026, 12:30 PM EDT - 3 months ago

BioAge Labs Slides: FY 2026


BioAge Labs reports Q1 EPS (52c), consensus (63c)

2026-05-08T15:21:29.000Z - 3 months ago

BioAge Labs reports Q1 EPS (52c), consensus (63c)


BioAge Labs Quarterly report: Q1 2026

May 8, 2026, 7:00 AM EDT - 3 months ago

BioAge Labs Quarterly report: Q1 2026


BioAge Labs Earnings release: Q1 2026

May 8, 2026, 7:00 AM EDT - 3 months ago

BioAge Labs Earnings release: Q1 2026


BioAge Labs Transcript: Study result

Apr 21, 2026, 8:00 AM EDT - 4 months ago

BioAge Labs Transcript: Study result


BioAge Labs Press release: Study result

Apr 21, 2026, 8:00 AM EDT - 4 months ago

BioAge Labs Press release: Study result


BioAge Labs Proxy statement: Proxy filing

Apr 21, 2026, 8:00 AM EDT - 4 months ago

BioAge Labs Proxy statement: Proxy filing


BioAge Labs Proxy statement: Proxy filing

Apr 21, 2026, 8:00 AM EDT - 4 months ago

BioAge Labs Proxy statement: Proxy filing


BioAge Labs Slides: Corporate presentation

Apr 20, 2026, 7:00 AM EDT - 4 months ago

BioAge Labs Slides: Corporate presentation


BioAge Labs initiated with a Buy at Needham

2026-03-27T10:27:07.000Z - 5 months ago

BioAge Labs initiated with a Buy at Needham


BioAge Labs files automatic mixed securities shelf

2026-03-24T20:25:15.000Z - 5 months ago

BioAge Labs files automatic mixed securities shelf


BioAge Labs Annual report: Q4 2025

Mar 24, 2026, 9:00 AM EDT - 5 months ago

BioAge Labs Annual report: Q4 2025


BioAge Labs Earnings release: Q4 2025

Mar 24, 2026, 9:00 AM EDT - 5 months ago

BioAge Labs Earnings release: Q4 2025


BioAge Labs Slides: Corporate presentation

Mar 24, 2026, 7:00 AM EDT - 5 months ago

BioAge Labs Slides: Corporate presentation


BioAge Labs price target raised to $52 from $15 at Citi

2026-03-10T10:41:09.000Z - 6 months ago

BioAge Labs price target raised to $52 from $15 at Citi


BioAge Labs initiated with an Outperform at Oppenheimer

2026-02-24T21:48:29.000Z - 6 months ago

BioAge Labs initiated with an Outperform at Oppenheimer

VTYX


BioAge Announces Pricing of Upsized $115.0 Million Public Offering

Jan 21, 2026, 10:30 PM EST - 7 months ago

BioAge Announces Pricing of Upsized $115.0 Million Public Offering


BioAge Announces Proposed Public Offering

Jan 20, 2026, 4:01 PM EST - 7 months ago

BioAge Announces Proposed Public Offering


BioAge Labs Slides: Corporate presentation

Jan 20, 2026, 7:00 AM EST - 7 months ago

BioAge Labs Slides: Corporate presentation


BioAge Labs Quarterly report: Q3 2025

Nov 6, 2025, 4:00 PM EST - 10 months ago

BioAge Labs Quarterly report: Q3 2025


BioAge Labs Earnings release: Q3 2025

Nov 6, 2025, 4:00 PM EST - 10 months ago

BioAge Labs Earnings release: Q3 2025


BioAge Labs Registration statement: Registration Filing

Nov 5, 2025, 7:00 AM EST - 10 months ago

BioAge Labs Registration statement: Registration Filing


BioAge Labs Registration statement: Registration Filing

Nov 5, 2025, 7:00 AM EST - 10 months ago

BioAge Labs Registration statement: Registration Filing


BioAge Labs Registration statement: Registration Filing

Oct 2, 2025, 8:00 AM EDT - 11 months ago

BioAge Labs Registration statement: Registration Filing


BioAge Labs Registration statement: Registration Filing

Oct 2, 2025, 8:00 AM EDT - 11 months ago

BioAge Labs Registration statement: Registration Filing


BioAge Labs Quarterly report: Q2 2025

Aug 6, 2025, 4:00 PM EDT - 1 year ago

BioAge Labs Quarterly report: Q2 2025


BioAge Labs Earnings release: Q2 2025

Aug 6, 2025, 4:00 PM EDT - 1 year ago

BioAge Labs Earnings release: Q2 2025


BioAge Labs Slides: Investor Presentation

Jun 4, 2025, 6:00 AM EDT - 1 year ago

BioAge Labs Slides: Investor Presentation


BioAge Labs Quarterly report: Q1 2025

May 6, 2025, 12:00 AM EDT - 1 year ago

BioAge Labs Quarterly report: Q1 2025


BioAge Labs Earnings release: Q1 2025

May 6, 2025, 12:00 AM EDT - 1 year ago

BioAge Labs Earnings release: Q1 2025


BioAge Labs Proxy statement: Proxy Filing

Apr 17, 2025, 8:00 AM EDT - 1 year ago

BioAge Labs Proxy statement: Proxy Filing


BioAge Labs Proxy statement: Proxy Filing

Apr 17, 2025, 8:00 AM EDT - 1 year ago

BioAge Labs Proxy statement: Proxy Filing


BioAge Labs Annual report: Q4 2024

Mar 20, 2025, 5:00 PM EDT - 1 year ago

BioAge Labs Annual report: Q4 2024


BioAge Labs Earnings release: Q4 2024

Mar 20, 2025, 5:00 PM EDT - 1 year ago

BioAge Labs Earnings release: Q4 2024


B2iDigital
B2iDigital Aug. 25 at 8:42 PM
BioAge Labs, Inc. ($BIOA ) meets investors at the 5th Annual ROTH Healthcare Opportunities Conference, hosted by ROTH Capital Partners at The Metropolitan Club in New York City on Tuesday, September 29, 2026, where B2i Digital is the Marketing Partner. The 5th Annual ROTH Healthcare Opportunities Conference is a B2i Digital Featured Conference. See event details and profiles of participating companies at: https://b2idigital.com/5th-annual-roth-healthcare-opportunities-conference BioAge Labs is a clinical-stage biopharmaceutical company working on metabolic disease: • The company develops therapeutic products for metabolic diseases such as obesity by targeting human biology • Azelaprag is a potential oral therapeutic for obesity • Several earlier-stage metabolic programs sit behind it in the pipeline • The company was founded on April 1, 2015 and is headquartered in Emeryville, California Credit to the team at ROTH: Byron Roth, Aaron Gurewitz, Isabel Mattson-Pain, Nazan Akdeniz, Otilia "Charo" Montano, Amanda McAdams, James Antonopoulos, Benjamin Bowen, Kris Salinger, Jason Wittes and Boobalan Pachaiyappan, Ph.D. ROTH built the day around time with management, in a 25-minute 1-on-1 and small group format running from 8:00 AM to 4:30 PM that gives institutional investors extended interaction with the executives running these companies. This is an invitation-only event and registration is subject to approval by ROTH. To request registration: https://www.meetmax.com/sched/event_139361/conference_home.html Participating company website: http://www.bioagelabs.com/ B2i Digital, The Capital Markets Matchmaker℠, carries each participating company's story From Marketing to Meetings℠, across its media network with a combined monthly audience of more than 330 million and its own community of 1.7 million+ investors and market participants. ROTH is a relationship-driven investment bank headquartered in Newport Beach, California, focused on serving growth companies and their investors. Learn more at https://www.roth.com. Discover more Featured Companies, Featured Experts, and upcoming Featured Conferences at b2idigital.com. B2i Digital is not a broker-dealer or investment adviser. This post is informational and not an offer or solicitation regarding any security. See the complete Disclosure at https://b2idigital.com/disclaimer.
1 · Reply
teddy2
teddy2 Aug. 21 at 4:32 AM
$BIOA lol this is crazy, it fell because of a different companie’s outcome. Check out the current target prices.
1 · Reply
Rusty_Shackelford2024
Rusty_Shackelford2024 Aug. 19 at 9:54 PM
$BIOA weird volume at the end of the day I think there’s gonna be some kind of announcement tomorrow. Let’s see that pop back to 15. Remember, we’re paying for the sins of Novo. The Street maintains the price target 🤌🏻🤌🏻🤌🏻🤌🏻
0 · Reply
BiodegradableBurger
BiodegradableBurger Aug. 19 at 3:49 PM
$BIOA p O s
0 · Reply
BiodegradableBurger
BiodegradableBurger Aug. 13 at 2:50 PM
$BIOA Anything alive?
0 · Reply
Rusty_Shackelford2024
Rusty_Shackelford2024 Aug. 12 at 12:36 AM
$BIOA this is a range trade between 10.60 and 11.50 right now
0 · Reply
forprofit12
forprofit12 Aug. 11 at 4:27 PM
$BIOA added
0 · Reply
TooMuchFinesse
TooMuchFinesse Aug. 9 at 4:48 AM
$BIOA Kind of late to scoop the over reaction news but I think I’ll start loading here
2 · Reply
TooMuchFinesse
TooMuchFinesse Aug. 8 at 6:22 PM
$CMPX $PMVP $BIOA $VIR What do these all have in common? Undervalued Institutions loaded Tang Capital & Orbimed ✅💰🔥 🕳️ 🐇
0 · Reply
Eko86
Eko86 Aug. 7 at 5:58 PM
$BIOA $8.88 entry because I like even numbers.... $20 sale pending lllol
1 · Reply
JFDI
JFDI Aug. 6 at 11:10 PM
$BIOA thru some alerts at 25, wonder if it’ll ever hit. who knows.
0 · Reply
Rusty_Shackelford2024
Rusty_Shackelford2024 Aug. 6 at 11:53 AM
$BIOA OH LAWD SHE RUNNING
0 · Reply
Rusty_Shackelford2024
Rusty_Shackelford2024 Aug. 5 at 6:02 PM
$BIOA man, I’m holding here with an average of 9.40 wanting to sell this position several thousand dollars into the green. It’s coiled up like a spring though and I can see this hit in 15 or 16 before the end of the week.
0 · Reply
izjustlooking
izjustlooking Aug. 5 at 4:12 PM
$BIOA get this back to 25
0 · Reply
BiodegradableBurger
BiodegradableBurger Aug. 5 at 2:27 PM
$BIOA Buying up started at 12pm yesterday so expecting the same…?
0 · Reply
teddy2
teddy2 Aug. 4 at 6:09 PM
$BIOA I hope they talk the talk on Thursday’s earnings!!!!
0 · Reply
Gemini367
Gemini367 Aug. 4 at 5:46 PM
$BIOA done. Let's see if we can break $12 and send it higher. Best of luck.
0 · Reply
bluermefox
bluermefox Aug. 4 at 5:09 PM
$BIOA Twitching here
0 · Reply
Rusty_Shackelford2024
Rusty_Shackelford2024 Aug. 4 at 11:46 AM
$BIOA easy win. 15 by close
0 · Reply
UnoffensiveName
UnoffensiveName Aug. 4 at 1:32 AM
$BIOA Dear everyone who likes money: Simply put... $BIOA is getting hit on guilt-by-association. The other drug failed due to a target-specific toxicity. BIOA's issue was idiosyncratic transaminitis without a clear dose-response—a different mechanism entirely. This isn't a class effect, so the sympathy selloff isn't scientifically justified. I'm loading here
1 · Reply
UnoffensiveName
UnoffensiveName Aug. 4 at 1:29 AM
$BIOA this cat's name should be BioRight instead of BioRich Why? Well... cuz hes right
0 · Reply
topstockalerts
topstockalerts Aug. 3 at 8:12 PM
$BIOA just watching how it reacts here… key spot
1 · Reply